James Beal

James Beal is an Assistant Professor in the Department of Pediatrics, specializing in pediatric hematology, immunology, and critical care medicine. His research addresses life-threatening conditions such as Hemophagocytic Lymphohistiocytosis (HLH) and Multiple Organ Dysfunction Syndrome (MODS), with a focus on innovative therapeutic strategies.

His recent publication (2023) demonstrates expertise in alternative HLH/MODS treatments using emapalumab, reflecting a research emphasis on immunotherapy and cytokine-targeted interventions in pediatric critical care.